ORDRCC

  • Welcome
  • Leadership
  • Administrative Core
  • Cores
    • Clinical Characterization and Biorepository Core
    • Human Phenotyping Core
    • Request Services
  • Investigator Support
    • Center Investigators
    • Proposal Development
    • Pilot Funding
  • For Patients
    • Get Involved
    • Getting to the Clinic
  • Discoveries
  • shutterstock_211939057

    What we're about



    Advancing prediction, prevention, and precision therapy for patients with rheumatic diseases
  • shutterstock_347560208

    Who we are



    Over 200 researchers spanning the basic, clinical, and analytical sciences
  • b2jyXojmp3qjCvjQxTK50QRmNNc2VNzkte8d3Oq2JOoRTKHVnmKyhHJawEB5A_QVtWgYzBFMgTvdcIe20Mtw0Q-1024×681

    How we help



    World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careers
  • DrMerrill_patientstudiesphoto-1024×569

    Why we care



    Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives

Extensive Cohort Collections

Our CAP-accredited biorepository manages some of the largest existing collections of SLE, Sjogren’s, RA, and osteoarthritis samples

Cutting Edge Methodologies

The Human Phenotyping Core offers single-cell technologies, including CyTOF, Spatial Transcriptomics, and scRNASeq

Clinical Research Expertise

A physician examines a patient's hand in an exam room
The Clinical Core assists with IRB approvals, study recruitment, and clinical research visits

RSS Recent Publications

  • 47XXY and 47XXX in Scleroderma and Myositis March 30, 2022
  • Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus January 10, 2022
  • Quantifying Chemical Composition and Reaction Kinetics of Individual Colloidally Dispersed Nanoparticles December 28, 2021
  • Nucleic Acid-Sensing and Interferon-Inducible Pathways Show Differential Methylation in MZ Twins Discordant for Lupus and Overexpression in Independent Lupus Samples: Implications for Pathogenic Mechanism and Drug Targeting December 24, 2021
  • Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis November 16, 2021
  • The intersection of COVID-19 and autoimmunity October 28, 2021
  • Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles October 4, 2021

Cite ORDRCC Support
Publications that used ORDRCC consultations, services, or resources should cite P30AR073750.

Oklahoma Rheumatic Disease Research Cores Center

At the Oklahoma Medical Research Foundation in Oklahoma City, OK

Copyright © 2017 Oklahoma Medical Research Foundation   Login

MENU
  • Welcome
  • Leadership
  • Administrative Core
  • Cores
    • Clinical Characterization and Biorepository Core
    • Human Phenotyping Core
    • Request Services
  • Investigator Support
    • Center Investigators
    • Proposal Development
    • Pilot Funding
  • For Patients
    • Get Involved
    • Getting to the Clinic
  • Discoveries